The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.m

Sarcoid-like granulomatosis (endo-/extrathoracic)

Publications

Berden FA, van Zwietering IM, Maan R, de Knegt RJ, Kievit W, Drenth JP

High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study.

Journal of gastrointestinal and liver diseases : JGLD 2016 Jun;25;197-204 — 2016 Jun — 197-204

Bräunlich J, Seyfarth HJ, Frille A, Wirtz H

Diffuse Interstitial Pulmonary Infiltrates in Malignant Melanoma.

Respiratory care 2015 Jul;60;e115-7 — 2015 Jul — e115-7

Trien R, Cooper CJ, Paez D, Colon E, Ajmal S, Salameh H

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C.

The American journal of case reports 2014;15;235-8 — 2014 — 235-8

Sahraian MA, Moghadasi AN, Owji M, Maboudi M, Kosari F, McGee JC, Minagar A

Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-?-1b: a case report.

Journal of medical case reports 2013 Dec 13;7;270 — 2013 Dec 13 — 270

Joshita S, Shirahata K, Yazaki Y, Okaniwa S, Nakamura Y, Kimura T, Noami S, Horigome R, Yagi H, Ito N, Yamazaki A, Akahane Y, Umemura T, Yoshizawa K, Tanaka E, Ota M

Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy.

Hepatology research : the official journal of the Japan Society of Hepatology 2013 Jul;43;801-7 — 2013 Jul — 801-7

Petousi N, Thomas EC

Interferon-?-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.

Journal of medical case reports 2012 Oct 08;6;344 — 2012 Oct 08 — 344

Meristoudis G, Tsaroucha A, Ilias I, Giannakopoulos V, Batsakis C, Christakopoulou J

Interferon-induced sarcoidosis with osseous involvement in a patient with melanoma.

Hellenic journal of nuclear medicine 2011 Jan-Apr;14;68-9 — 2011 Jan-Apr — 68-9

Oz GS, Emri S, Apras Bilgen S

Development of interferon induced sarcoidosis in a patient with familial mediterranean fever.

Tuberkuloz ve toraks 2008;56;319-24 — 2008 — 319-24

Doyle MK, Berggren R, Magnus JH

Interferon-induced sarcoidosis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2006 Oct;12;241-8 — 2006 Oct — 241-8

Akay BN, Ekmekci P, Sanli H, Celik G, Bozdayi M

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection.

Journal of the European Academy of Dermatology and Venereology : JEADV 2006 Apr;20;442-5 — 2006 Apr — 442-5

Ramos-Casals M, Mañá J, Nardi N, Brito-Zerón P, Xaubet A, Sánchez-Tapias JM, Cervera R, Font J,

Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.

Medicine 2005 Mar;84;69-80 — 2005 Mar — 69-80

Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ

Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma.

Cancer 1987 Mar 01;59;896-900 — 1987 Mar 01 — 896-900